ZYHCG HP 10K

Distributor inventory | Vial

Induction of ovulation in anovulatory infertility (e.g., PCOS) as part of fertility treatment; triggering final follicular maturation in assisted reproduction (IUI/IVF); treatment of male hypogonadotropic hypogonadism to stimulate testosterone/spermatogenesis; cryptorchidism in selected pediatric cases (as advised by specialist).

hCG acts like luteinizing hormone (LH). In women, it triggers final maturation and release of the egg and supports corpus luteum progesterone production. In men, it stimulates Leydig cells in the testes to produce testosterone.

For intramuscular (IM) or subcutaneous (SC) injection only, exactly as prescribed by a fertility/andrology specialist. Reconstitute the lyophilized powder with the provided diluent/sterile water and use immediately; do not shake vigorously. Dose and timing depend on protocol (commonly a single 10,000 IU “trigger” injection in fertility treatment).

Injection site pain/redness, headache, abdominal pain/bloating, nausea/vomiting, breast tenderness, mood changes/irritability, fatigue, ovarian enlargement, fluid retention

Use only under specialist supervision with ultrasound and hormone monitoring. Risk of ovarian hyperstimulation syndrome (OHSS), ovarian torsion and multiple pregnancy in women undergoing fertility treatment—seek urgent care for severe abdominal pain, rapid weight gain, shortness of breath, decreased urination or leg swelling. Contraindicated in hormone-dependent tumors (e.g., ovarian/uterine/breast cancer), primary ovarian failure, uncontrolled thyroid/adrenal disorders, pituitary tumor, abnormal uterine bleeding of unknown cause, and active thromboembolic disease (as clinically applicable). Use caution in patients with history of thrombosis, migraine, asthma, epilepsy, cardiac/renal disease or hyperprolactinemia. In men, may cause gynecomastia, acne, edema and can worsen prostate disease; monitor testosterone/hematocrit as advised. Not for intravenous use.

Gonadotropin-releasing hormone (GnRH) agonists/antagonists and other gonadotropins (FSH/hMG) may increase ovarian response and OHSS risk; concomitant fertility medicines should be used only per protocol. May interfere with pregnancy tests (false-positive) shortly after administration.

Store refrigerated at 2–8°C; do not freeze. Protect from light. After reconstitution, use immediately (or as per pack insert); discard any unused solution.

Ovitrelle 250 mcg Injection, Pregnyl 10000 IU Injection, Profasi HP 10000 IU Injection, HUCOG 10000 IU Injection, HCG Inj 10000 IU (various brands)